登革热发热期进展为重症的风险预测因素:系统综述与荟萃分析
该研究通过系统综述与荟萃分析,评估了发热期可检测的、与登革热进展为重症相关的预测因素。共纳入150篇文献,其中122篇进入荟萃分析,涉及25个潜在预测因素。结果显示女性、合并症、呕吐、腹痛、出血、体液蓄积、血小板降低、白蛋白降低、转氨酶升高、登革病毒2型及二次感染与重症相关。
要点
- 发热期呕吐、腹痛、出血、体液蓄积与重症登革热进展相关。
- 合并糖尿病、高血压、肾病或心血管病者重症风险更高。
- 发热早期血小板降低、白蛋白降低、转氨酶升高提示重症风险。
核心结论
- 支持监测2009年WHO指南中的预警信号。
- 发热期检测感染血清型并监测血小板、白蛋白、AST和ALT可能改善重症登革热的早期预测。
研究设计与样本
- 系统综述与荟萃分析,检索8个医学数据库1997年1月1日至2020年1月31日发表的英文临床研究。
- 最终纳入150篇文献进行系统综述,其中122篇涉及25个潜在预测因素进入荟萃分析。
- 使用随机效应模型估计合并效应量,仅纳入至少4项研究报道的预测因素。
- 异质性采用Cochrane Q和I2统计量评估,发表偏倚采用Egger检验。
- 进行了儿童和成人研究的亚组分析。
关键数值与推荐
- 登革病毒血清型2在儿童中与重症相关。
临床怎么用
- 对发热期登革热患者应监测WHO预警信号,如呕吐、腹痛、出血、体液蓄积。
- 发热早期可检测登革病毒血清型,并动态监测血小板计数、血清白蛋白、AST和ALT。
- 对合并糖尿病、高血压、肾病或心血管病的患者应提高重症警惕。
局限性
- 纳入研究在混杂因素方面存在中到高偏倚风险。
- 不同预测因素的合并结果异质性从低到高不等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ability to accurately predict early progression of dengue to severe disease is crucial for patient triage and clinical management. Previous systematic reviews and meta-analyses have found significant heterogeneity in predictors of severe disease due to large variation in these factors during the time course of the illness. We aimed to identify factors associated with progression to severe dengue disease that are detectable specifically in the febrile phase. METHODS: We did a systematic review and meta-analysis to identify predictors identifiable during the febrile phase associated with progression to severe disease defined according to WHO criteria. Eight medical databases were searched for studies published from Jan 1, 1997, to Jan 31, 2020. Original clinical studies in English assessing the association of factors detected during the febrile phase with progression to severe dengue were selected and assessed by three reviewers, with discrepancies resolved by consensus. Meta-analyses were done using random-effects models to estimate pooled effect sizes. Only predictors reported in at least four studies were included in the meta-analyses. Heterogeneity was assessed using the Cochrane Q and I2 statistics, and publication bias was assessed by Egger's test. We did subgroup analyses of studies with children and adults. The study is registered with PROSPERO, CRD42018093363. FINDINGS: Of 6643 studies identified, 150 articles were included in the systematic review, and 122 articles comprising 25 potential predictors were included in the meta-analyses. Female patients had a higher risk of severe dengue than male patients in the main analysis (2674 [16·2%] of 16 481 vs 3052 [10·5%] of 29 142; odds ratio [OR] 1·13 [95% CI 1·01-1·26) but not in the subgroup analysis of studies with children. Pre-existing comorbidities associated with severe disease were diabetes (135 [31·3%] of 431 with vs 868 [16·0%] of 5421 without; crude OR 4·38 [2·58-7·43]), hypertension (240 [35·0%] of 685 vs 763 [20·6%] of 3695; 2·19 [1·36-3·53]), renal disease (44 [45·8%] of 96 vs 271 [16·0%] of 1690; 4·67 [2·21-9·88]), and cardiovascular disease (nine [23·1%] of 39 vs 155 [8·6%] of 1793; 2·79 [1·04-7·50]). Clinical features during the febrile phase associated with progression to severe disease were vomiting (329 [13·5%] of 2432 with vs 258 [6·8%] of 3797 without; 2·25 [1·87-2·71]), abdominal pain and tenderness (321 [17·7%] of 1814 vs 435 [8·1%] of 5357; 1·92 [1·35-2·74]), spontaneous or mucosal bleeding (147 [17·9%] of 822 vs 676 [10·8%] of 6235; 1·57 [1·13-2·19]), and the presence of clinical fluid accumulation (40 [42·1%] of 95 vs 212 [14·9%] of 1425; 4·61 [2·29-9·26]). During the first 4 days of illness, platelet count was lower (standardised mean difference -0·34 [95% CI -0·54 to -0·15]), serum albumin was lower (-0·5 [-0·86 to -0·15]), and aminotransferase concentrations were higher (aspartate aminotransferase [AST] 1·06 [0·54 to 1·57] and alanine aminotransferase [ALT] 0·73 [0·36 to 1·09]) among individuals who progressed to severe disease. Dengue virus serotype 2 was associated with severe disease in children. Secondary infections (vs primary infections) were also associated with severe disease (1682 [11·8%] of 14 252 with vs 507 [5·2%] of 9660 without; OR 2·26 [95% CI 1·65-3·09]). Although the included studies had a moderate to high risk of bias in terms of study confounding, the risk of bias was low to moderate in other domains. Heterogeneity of the pooled results varied from low to high on different factors. INTERPRETATION: This analysis supports monitoring of the warning signs described in the 2009 WHO guidelines on dengue. In addition, testing for infecting serotype and monitoring platelet count and serum albumin, AST, and ALT concentrations during the febrile phase of illness could improve the early prediction of severe dengue. FUNDING: Wellcome Trust, National Institute for Health Research, Collaborative Project to Increase Production of Rural Doctors, and Royal Thai Government.
引用
- Sangkaew S, Ming D, Boonyasiri A, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021. PMID: 33640077. doi:10.1016/S1473-3099(20)30601-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。